The vaccine and healthcare sectors in China and Hong Kong generally declined

Vaccine stocks in China and Hong Kong generally declined; Hong Kong stock Cansino Biotech's decline widened to 20%, and Fosun Pharmaceutical fell by more than 17%. A-share biovaccine stocks continued to fall, Fosun Pharmaceuticals fell to a standstill, and Zhifei Biotech and Cansino-U fell more than 13%